BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 26600217)

  • 21. Hepatitis C virus and the immune system: a concise review.
    Gremion C; Cerny A
    Rev Med Virol; 2005; 15(4):235-68. PubMed ID: 15782389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Reconstitution After HCV Clearance With Direct Antiviral Agents: Potential Consequences for Patients With HCC?
    Werner JM; Adenugba A; Protzer U
    Transplantation; 2017 May; 101(5):904-909. PubMed ID: 27941432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug abuse, innate immunity and hepatitis C virus.
    Zhang T; Li Y; Ho WZ
    Rev Med Virol; 2006; 16(5):311-27. PubMed ID: 16933366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.
    Tan AT; Koh S; Goh W; Zhe HY; Gehring AJ; Lim SG; Bertoletti A
    J Hepatol; 2010 Mar; 52(3):330-9. PubMed ID: 20137825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune regulation in chronic hepatitis C virus infection.
    Hartling HJ; Ballegaard VC; Nielsen NS; Gaardbo JC; Nielsen SD
    Scand J Gastroenterol; 2016 Nov; 51(11):1387-97. PubMed ID: 27436030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival.
    Barnaba V
    J Hepatol; 2010 Oct; 53(4):752-61. PubMed ID: 20673595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the immunopathogenesis of chronic hepatitis C.
    Diepolder HM
    Antiviral Res; 2009 Jun; 82(3):103-9. PubMed ID: 19428600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Tim-3 in hepatitis B virus infection: An overview.
    Liu Y; Gao LF; Liang XH; Ma CH
    World J Gastroenterol; 2016 Feb; 22(7):2294-303. PubMed ID: 26900291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection.
    Soota K; Maliakkal B
    World J Gastroenterol; 2014 Nov; 20(43):16184-90. PubMed ID: 25473172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
    Pachiadakis I; Pollara G; Chain BM; Naoumov NV
    Lancet Infect Dis; 2005 May; 5(5):296-304. PubMed ID: 15854885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus: from immunobiology to immunotherapy.
    Grimm D; Heeg M; Thimme R
    Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.
    Liu S; Zhang Q; Shao X; Wang W; Zhang C; Jin Z
    Int Immunopharmacol; 2017 Sep; 50():87-94. PubMed ID: 28644966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate and adaptive immune responses in hepatitis B virus infection.
    Das A; Maini MK
    Dig Dis; 2010; 28(1):126-32. PubMed ID: 20460900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.